Pivotal Phase III study

First patient enrolled in Isofol’s AGENT study
in 1st line metastatic colorectal cancer

Read More

Arfolitixorin
- a drug candidate
for colorectal cancer

Read more

More than 365 000 CRC patients
could be treated with arfolitixorin

Read more

Previous

Next

Startpage 2

Upcoming Events